Gala Precision Engineering Ltd.'s IPO is open for subscription. The company plans to raise ₹ 167.93 crores in the upper price band through this IPO.

India’s biotech sector has witnessed an extraordinary transformation, expanding from just 52 startups in 2014 to over 6,300 today. This 100-fold growth underscores the sector's vast potential and crucial role in shaping the future of healthcare and pharmaceuticals.

Hyundai Motor India’s IPO will be the first by an automobile company in India in over two decades. It will not involve a fresh issue, only an offer for sale.

Premier Energies Ltd, India’s second-largest integrated solar cell and solar module manufacturer, is all set to launch its initial public offering (IPO) through a fresh issue and an offer for sale.

Indian pharmaceutical stocks may experience a potential resurgence in 2024, driven by increasing exports, strategic shifts in global markets, and a rising demand for affordable healthcare. Let’s explore the key drivers behind this resurgence and highlight the companies to watch as the industry charts a promising path forward.

What will it take to have a repeat of the past decade in India? Understand the essential factors, emerging trends, and potential hurdles that could influence India’s growth curve to replicate its past market success.

Regarding personal finance and investments, mutual funds, especially equity funds, always have an interesting discussion. The equity market is on a bull run, with the Sensex and Nifty touching new highs

The stage is set for the water infra industry as Budget 2024 floods the space with massive funding. Here’s what you need to know…

Brainbees Solutions Limited, which operates the FirstCry retail platform, will launch its IPO on the 6th of August consisting of a fresh issue and an offer for sale.

As buyback fever sweeps through Dalal Street, let’s examine how to approach the upcoming buyback season using a couple of past examples.